Women with breast cancer and a BRCA1 or BRCA2 mutation face high risks of contralateral breast cancer, and many opt for bilateral mastectomy. We used a simulation approach to predict the benefit of risk-reducing mastectomy (RRM) on 20-year survival.
- Vasily Giannakeas
- Steven A. Narod
